15 May 2023 --- Allergan Aesthetics, an AbbVie company, has gained approval from the US Food and Drug Administration (FDA) for Skinvive by Juvéderm, marketed as the “first and only” hyaluronic acid intradermal microdroplet injection for skin smoothness available in the US.With results lasting through six months with optimal treatment, the solution improves skin smoothness of the cheeks in adults over the age of 21, leading to a lasting glow, the company claims.
